Tue, December 5, 2017
Mon, December 4, 2017
Fri, December 1, 2017
Thu, November 30, 2017
Wed, November 29, 2017
Tue, November 28, 2017
Mon, November 27, 2017
Wed, November 22, 2017
Tue, November 21, 2017
Mon, November 20, 2017
Fri, November 17, 2017
Thu, November 16, 2017
Wed, November 15, 2017
Tue, November 14, 2017
Mon, November 13, 2017
Fri, November 10, 2017
Thu, November 9, 2017
Wed, November 8, 2017

Alex Arfaei Maintained (ABBV) at Hold with Increased Target to $84 on, Nov 16th, 2017


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-84-on-nov-16th-2017.html
Published in Stocks and Investing on by   Print publication without navigation


Alex Arfaei of BMO Capital, Maintained "AbbVie Inc." (ABBV) at Hold with Increased Target from $66 to $84 on, Nov 16th, 2017.

Alex has made no other calls on ABBV in the last 4 months.



There are 7 other peers that have a rating on ABBV. Out of the 7 peers that are also analyzing ABBV, 3 agree with Alex's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Marc Goodman of "UBS" Maintained at Hold with Increased Target to $95 on, Friday, October 13th, 2017
  • Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $90 on, Friday, October 13th, 2017
  • Gregg Gilbert of "Deutsche Bank" Maintained at Hold with Increased Target to $66 on, Monday, July 17th, 2017


These are the ratings of the 4 analyists that currently disagree with Alex


  • Geoffrey Porges of "Leerink Swann" Maintained at Buy with Decreased Target to $107 on, Monday, October 30th, 2017
  • Steve Scala of "Cowen & Co." Upgraded from Hold to Buy on, Wednesday, October 11th, 2017
  • Jeffrey Holford of "Jefferies" Maintained at Strong Buy with Increased Target to $107 on, Friday, September 15th, 2017
  • Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $95 on, Thursday, August 17th, 2017